428 related articles for article (PubMed ID: 24439532)
1. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.
Bagos PG
Mol Hum Reprod; 2009 Jan; 15(1):19-26. PubMed ID: 19066200
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor 1 and methylenetetrahydrofolate reductase gene mutations in iranian women with polycystic ovary syndrome.
Idali F; Zareii S; Mohammad-Zadeh A; Reihany-Sabet F; Akbarzadeh-Pasha Z; Khorram-Khorshid HR; Zarnani AH; Jeddi-Tehrani M
Am J Reprod Immunol; 2012 Nov; 68(5):400-7. PubMed ID: 22882325
[TBL] [Abstract][Full Text] [Related]
4. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.
Zhang TT; Yuan L; Yang YM; Ren Y
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2326-31. PubMed ID: 25219833
[TBL] [Abstract][Full Text] [Related]
5. [Association of genetic polymorphisms in plasminogen activator inhibitor-1 gene and 5,10-methylenetetrahydrofolate reductase gene with recurrent early spontaneous abortion].
Guan LX; Du XY; Wang JX; Gao L; Wang RL; Li HB; Wang SX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):330-3. PubMed ID: 15952129
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
Diamanti-Kandarakis E; Palioniko G; Alexandraki K; Bergiele A; Koutsouba T; Bartzis M
Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
Glueck CJ; Sieve L; Zhu B; Wang P
Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
[TBL] [Abstract][Full Text] [Related]
8. MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome.
Radaković B; Goldstajn MS
Coll Antropol; 2007 Sep; 31(3):919-21. PubMed ID: 18041407
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism and polycystic ovary syndrome.
Kilicci C; Bayram B; Ozkurt M; Onlu H; Erkasap N; Mutlu F
Genet Test Mol Biomarkers; 2011; 15(7-8):565-7. PubMed ID: 21413876
[TBL] [Abstract][Full Text] [Related]
10. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
Lin S; Huiya Z; Bo L; Wei W; Yongmei G
Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.
Liu Y; Sun MG; Jiang R; Ding R; Che Z; Chen YY; Yao CJ; Zhu XX; Cao JY
J Assist Reprod Genet; 2014 Mar; 31(3):363-70. PubMed ID: 24435452
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator and plasminogen activator inhibitor-1 gene polymorphisms in patients with chronic periodontitis.
Gürkan A; Emingil G; Saygan BH; Cinarcik S; Atilla G; Köse T; Berdeli A
J Periodontol; 2007 Jul; 78(7):1256-63. PubMed ID: 17608581
[TBL] [Abstract][Full Text] [Related]
13. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH
Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome.
Nsrallah AA; Abd-El Fatah AH; Ahmed HS
J Gene Med; 2019 Apr; 21(4):e3076. PubMed ID: 30743312
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome.
Sun L; Lv H; Wei W; Zhang D; Guan Y
J Endocrinol Invest; 2010 Feb; 33(2):77-82. PubMed ID: 19636212
[TBL] [Abstract][Full Text] [Related]
16. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome.
Karadeniz M; Erdogan M; Berdeli A; Saygili F; Yilmaz C
J Assist Reprod Genet; 2007 Sep; 24(9):412-8. PubMed ID: 17661167
[TBL] [Abstract][Full Text] [Related]
17. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
[TBL] [Abstract][Full Text] [Related]
18. Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.
Fu LY; Dai LM; Li XG; Zhang K; Bai Y
Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():56-61. PubMed ID: 24192663
[TBL] [Abstract][Full Text] [Related]
19. Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with genetic susceptibility to polycystic ovary syndrome: A PRISMA-compliant meta-analysis.
Zhu X; Hong X; Chen L; Xuan Y; Huang K; Wang B
Gene; 2019 Nov; 719():144079. PubMed ID: 31454542
[TBL] [Abstract][Full Text] [Related]
20. Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients.
Wang B; Xu P; Shu Q; Yan S; Xu H
Clin Appl Thromb Hemost; 2021; 27():10760296211031291. PubMed ID: 34325549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
